Navigation Links
Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
Date:8/13/2013

New York, New York (PRWEB) August 13, 2013

Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) involving allegations that the drug caused users to suffer life-threatening episodes of internal bleeding continue to move forward in a multidistrict litigation now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Case Management Order dated August 9th, the Court has established some limitations that address certain ex parte communications. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“Our Firm continues to hear from individuals who have allegedly suffered severe internal bleeding, a potentially life-threatening Pradaxa side effect. We are pleased to see this litigation moving forward, and are looking forward to the commencement of bellwether trials next year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Lawsuits
Court documents indicate that more than 1,390 Pradaxa lawsuits are currently pending in the multidistrict litigation underway in the Southern District of Illinois, all of which allege that Boehringer Ingelheim failed to provide adequate warnings regarding Pradaxa side effects, particularly the lack of an antidote for internal bleeding. The first bellwether trial in the Pradaxa bleeding litigation is scheduled to start in September 2014.

Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2012 to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. According to a recent Bloomberg.com report, the drug was positioned as an improvement over warfarin, a blood thinner that has been on the market for decades. While both drugs are known to sometimes cause serious incidents of internal bleeding, there is no readily available antidote for Pradaxa bleeding. However, similar hemorrhaging that may occur in warfarin patients can be stopped via the administration of vitamin K.* In January, an analysis appearing in the QuarterWatch Report from the Institute for Safe Medicine Practices (ISMP) found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding. The authors of that analysis surmised that the lack of an antidote for Pradaxa patients may contribute to the higher death rate associated with the drug.

Individuals who have suffered serious episodes of internal bleeding while taking Pradaxa may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Learn More about Pradaxa bleeding at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11022986.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
2. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
3. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Scheduling of Next Case Management Conference in Federal Pradaxa Bleeding Litigation
4. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
5. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
6. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
7. Pradaxa Lawsuit Attorneys at Wright & Schulte LLC Report on Scheduling of Bellwether Trials in Federal Pradaxa Bleeding Lawsuits
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
9. New Lawsuit on Pradaxa Bleeding: Now, AttorneyOne Can Provide Advice
10. New Study Casts Doubt on FDA Pradaxa Conclusions
11. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Side Effects Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... First Choice Emergency Room , ... Howard Ng, as the new Medical Director of its Pflugerville- FM 685 facility. ... Director of our Pflugerville- FM 685 location,” said Dr. Stephen Van Roekel, Reginal Medical ...
(Date:9/19/2017)... ... 2017 , ... The Davidson Institute for Talent Development will ... 27 at a reception in Washington D.C. The recipients received $50,000, $25,000 and ... “I am honored to be a Davidson Fellow Laureate,” said Rishab Gargeya, a ...
(Date:9/19/2017)... ... 19, 2017 , ... MarkeTouch Media has partnered with fred’s ... a modern design with a more streamlined user experience and is designed to ... app includes hundreds of digital coupons that can be clipped to a customer’s ...
(Date:9/18/2017)... ... , ... TransLuma is a set of dissolving transitions created for use within Final Cut ... luminance of a scene without the use of keyframes. Choose to bleed away ... , TransLuma allows editors to gradually dissolve away the light in a scene to reveal ...
(Date:9/18/2017)... ... , ... A September 7 article on BBC News describes new ... world’s most common and least expensive medications, may be able to stimulate stem cells ... California Dental Group and Calabasas Dental Care says that, while it’s likely to be ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... , Sept. 1, 2017 Michael ... Solutions, Inc , highlights opportunities for growth in his ... report that Marlin Equity is seeking a buyer for ... annual award-winning 22-year-old healthcare solutions Value Added Reseller and ... "As the healthcare market ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... ivWatch, LLC, the leading provider of continuous monitoring devices for the ... an Innovative Technology contract from Vizient, Inc., the largest member-driven health ... ... detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch based on ...
Breaking Medicine Technology: